FDA Inspection 1064288 — Mithra Pharmaceuticals Cdmo SA
The FDA completed an inspection of Mithra Pharmaceuticals Cdmo SA on Aug 2, 2018 in Flemalle. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 2, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Flemalle (Belgium)